WALTHAM, Mass., Nov. 17, 2014 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with kidney and vascular diseases, announced today that Company management will present at the Stifel Nicolaus 2014 Healthcare Conference in New York City on Tuesday, November 18, 2014 at 2:25 pm ET.
About Proteon Therapeutics
Proteon Therapeutics Inc. is developing novel, first-in-class pharmaceuticals to address the medical needs of patients with kidney and vascular diseases. The company is headquartered in Waltham, Mass. For additional information, please visit www.proteontherapeutics.com.
CONTACT: Investor Contact George Eldridge, Senior Vice President and Chief Financial Officer 781-890-0102 firstname.lastname@example.org Press Contact Chris Erdman or Lynnea Olivarez, MacDougall Biomedical Communications 781-235-3060 email@example.com
Source:Proteon Therapeutics Inc.